Table 3.
N | Intercept | No physical dysfunction |
UE impairment |
LE impairment |
Mobility limitation |
|
---|---|---|---|---|---|---|
Cognitive performance | ||||||
Model 1 | 327 | 24.06±0.38 (p<0.001) |
0 | −2.06±1.01 (p=0.043) |
−3.59±0.69 (p<0.001) |
−4.41±1.00 (p<0.001) |
Model 2 | 295 | 35.12±3.80 (p<0.001) |
0 | −1.56±1.07 (p=0.147) |
−2.99±0.75 (p<0.001) |
−3.69±1.09 (p<0.001) |
Model 3 | 279 | 35.47±3.77 (p<0.001) |
0 | −1.43±1.05 (p=0.175) |
−2.95±0.77 (p<0.001) |
−3.78±1.09 (p<0.001) |
Cognitive impairment | ||||||
Model 1 | 327 | 2.37±0.26 (p<0.001) |
0 | −0.76±0.56 (p=0.171) |
−1.48±0.36 (p<0.001) |
−1.63±0.46 (p<0.001) |
Model 2 | 295 | 7.87±2.57 (p=0.002) |
0 | −0.41±0.66 (p=0.529) |
−1.11±0.43 (p=0.010) |
−1.15±0.57 (p=0.047) |
Model 3 | 279 | 8.44±2.71 (p=0.002) |
0 | −0.44±0.67 (p=0.515) |
−1.27±0.46 (p=0.006) |
−1.27±0.61 (p=0.038) |
Notes:
N=number of subjects; values represent estimated effect on outcome ±standard error (p value); GS=handgrip strength; LE=lower extremity;
Model 1 adjusted for age, gender, and race/ethnicity; Model 2 adjusted for age, gender, race/ethnicity, height, abdominal/hip girth ratio, and total number of comorbidities; Model 3 adjusted for age, gender, race/ethnicity, height, abdominal/hip girth ratio, total number of comorbidities, and depressive symptoms. Physical limitation was measured by presence of impairment in both grip strength and lower extremity.